US-based privately-held therapeutic antibody firm AnaptysBio has commenced an antibody development program with Momenta Pharmaceuticals, focused on the development of new antibodies against a therapeutically relevant target. Both the ...
Receptos, a biopharmaceutical company, has announced that Ono Pharmaceuticals has elected to amend and expand the existing collaboration agreement between the parties to include transfer to Ono of the Receptos G-protein-coupled receptor ...
Tags: Pharmaceuticals, Receptos
Single Cell Technology (SCT) and AB Biosciences (ABB) have entered into a collaboration to identify new therapeutic antibodies. Under the deal, SCT will use its patented platform to screen plasma cells, measure the kinetics of secreted ...
BioInvent International has secured a US patent for its antibody and concomitant target discovery technology F.I.R.S.T., a novel and unique discovery method, which allows for antibodies and disease targets to be identified simultaneously. ...
Integral Molecular, a biotechnology company, has announced the issuance of a new patent and patent family by the United States Patent and Trademark Office (USPTO) covering the composition of matter for its Lipoparticle technology. This ...
Tags: Lipoparticle Technology, USPTO
US-based drug discovery and development firm, Heptares Therapeutics has delivered the first stabilised G protein-coupled receptor (GPCR) called 'StaR' to MorphoSys for antibody discovery as part of their antibody therapeutics alliance. ...
Tags: Heptares Therapeutics, drug
arGEN-X, a clinical stage human monoclonal antibody therapeutics company, cin its SIMPLE Antibody research program collaboration with Shire Pharmaceuticals' Human Genetic Therapies division. The milestone, which was the first ...
Adimab signed a multi-target discovery agreement with Celgene Corporation, pursuant to which, Adimab will use its proprietary discovery and optimization platform to generate fully human antibodies against multiple targets. Under the terms ...
Tags: Adimab, Drug Discovery
Adimab and Innovent have collaborated to discover, develop and commercialise an antibody-based therapeutic, using Adimab antibody discovery and optimization platform, against a selected specific target. All initial product development ...
Tags: Adimab, Antibody-Based Therapeutic
MorphoSys and Heptares Therapeutics have signed a research deal to develop antibody therapeutics against G protein-coupled receptors (GPCRs). According to the deal, Heptares will produce stabilized receptors (StaRs) for MorphoSys proposed ...
Tags: antibody therapeutics, Heptares Therapeutics, GPCR disease
U3 Pharma, an antibody targeted cancer drug development affiliate of Daiichi Sankyo, has signed a research collaboration deal with AbCheck. AbCheck's commercial multi antibody discovery platforms include AbSieve, which combines the ...
Cell Signaling Technology (CST) has developed monoclonal antibody discovery platform, NG-XMT, for antigen-specific monoclonal antibodies. The antibody discovery technology combines the power of proteomics to identify and clone ...
Tags: NG-XMT, clone, monoclonal antibodies
Antibody-drug conjugate (ADC) company, Mersana Therapeutics and Adimab have initiated a joint effort to offer integrated antibody discovery and ADC technologies. The partnership will provide pharmaceutical companies an access to Adimab's ...
Tags: Adimab, Mersana, integrated antibody discovery, ADC technologies
Evotec has signed a strategic collaboration agreement to offer antibody discovery and development service to 4-Antibody. Evotec's high content screening combined with 4-Antibody's antibody selection approach will offer new possibilities ...
Tags: antibody discovery, 4-Antibody, human monoclonal antibodies